Overall, this study evidenced specifically that bisindole-substituted 3AP could be a useful prototype for the discovery of novel therapeutic agents to tackle AD and other GSK-3β-associated complex neurological syndromes [41]. The gene discussed is GSK3B; the disease is Alzheimer disease.